Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Empagliflozin is approved by both the FDA and EMA for the treatment of heart failure, including congestive heart failure (CHF). This approval covers heart failure with reduced ejection fraction (HFrEF) as well as preserved ejection fraction (HFpEF), independent of the presence of type 2 diabetes
The treatment with the SGLT2 inhibitor Empagliflozin in the EMPEROR-Preserved st…